Top Pharmaceuticals companies in Hong Kong by EBITDA
Hong Kong
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.98 B
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
| 2 |
USD 983.05 M
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
|
| 3 |
USD 560.12 M
|
Dec. 31, 2023 | USD 1.42 | 0.70% |
|
Hong Kong |
|
| 4 |
USD 411.58 M
|
Dec. 31, 2023 | USD 0.91 | -0.72% |
|
Hong Kong |
|
| 5 |
USD 360.13 M
|
Dec. 31, 2023 | USD 0.26 | 1.45% |
|
Hong Kong |
|
| 6 |
USD 270.73 M
|
Dec. 31, 2023 | USD 0.41 | 1.55% |
|
Hong Kong |
|
| 7 |
USD 138.31 M
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
| 8 |
USD 99.80 M
|
Dec. 31, 2023 | USD 1.04 | 1.48% |
|
Hong Kong |
|
| 9 |
USD 76.44 M
|
Dec. 31, 2023 | USD 0.49 | 2.14% |
|
Hong Kong |
|
| 10 |
USD 76.26 M
|
March 31, 2024 | USD 0.27 | 0.92% |
|
Hong Kong |
|
| 11 |
USD 70.28 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
| 12 |
USD 67.27 M
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
| 13 |
USD 62.57 M
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
| 14 |
USD 53.97 M
|
Dec. 31, 2023 | USD 0.47 | -0.57% |
|
Hong Kong |
|
| 15 |
USD 46.08 M
|
Dec. 31, 2023 | USD 0.25 | 3.70% |
|
Hong Kong |
|
| 16 |
USD 45.63 M
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
| 17 |
USD 45.02 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
| 18 |
USD 33.25 M
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
| 19 |
USD 31.89 M
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
| 20 |
USD 28.20 M
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
|
| 21 |
USD 24.72 M
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
Hong Kong |
|
| 22 |
USD 17.52 M
|
Dec. 31, 2023 | USD 0.31 | 0.39% |
|
Hong Kong |
|
| 23 |
USD 11.29 M
|
Dec. 31, 2023 | USD 0.21 | 10.11% |
|
Hong Kong |
|
| 24 |
USD -65.04 K
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
| 25 |
USD -3.62 M
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
|
| 26 |
USD -28.24 M
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
| 27 |
USD -47.90 M
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
| 28 |
USD -72.36 M
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
|
| 29 |
USD -1.12 B
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
Frequently Asked Questions
-
Which Pharmaceuticals company in Hong Kong has the highest EBITDA ?
The Pharmaceuticals company in Hong Kong with the highest EBITDA is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 1.98 B.
-
Which Pharmaceuticals company in Hong Kong has the lowest EBITDA ?
The Pharmaceuticals company in Hong Kong with the lowest EBITDA is BeiGene, Ltd. (HKSE: 6160.HK) at USD -1.12 B.
-
What are the top 10 Pharmaceuticals companies in Hong Kong by EBITDA ?
The top 10 Pharmaceuticals companies in Hong Kong by EBITDA are China Resources Pharmaceutical Group Limited, Sino Biopharmaceutical Limited, The United Laboratories International Holdings Limited, China Medical System Holdings Limited, China Traditional Chinese Medicine Holdings Co. Limited, SSY Group Limited, Alibaba Health Information Technology Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited, Lee & Man Chemical Company Limited and Perfect Medical Health Management Limited.
-
What are the bottom 10 Pharmaceuticals companies in Hong Kong by EBITDA ?
The bottom 10 Pharmaceuticals companies in Hong Kong by EBITDA are BeiGene, Ltd., Sirnaomics Ltd., Prenetics Global Limited, SinoMab BioScience Limited, Regencell Bioscience Holdings Limited, Yunnan Energy International Co. Limited, Chia Tai Enterprises International Limited, Pak Fah Yeow International Limited, Lee's Pharmaceutical Holdings Limited and JBM (Healthcare) Limited.